DK1731605T3 - Cancerantigenpeptider der er afledt af WT1 - Google Patents

Cancerantigenpeptider der er afledt af WT1

Info

Publication number: DK1731605T3
Authority: DK; Denmark
Prior art keywords: peptides derived; cancer antigen; antigen peptides; peptide; cancer
Prior art date: 2004-03-31

Application number

DK05727848.3T

Other languages

English (en)

Inventor

Haruo Sugiyama

Original Assignee

Int Inst Cancer Immunology Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-31

Filing date

2005-03-30

Publication date

2010-05-25

2005-03-30 Application filed by Int Inst Cancer Immunology Inc filed Critical Int Inst Cancer Immunology Inc

2010-05-25 Application granted granted Critical

2010-05-25 Publication of DK1731605T3 publication Critical patent/DK1731605T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4242—Transcription factors, e.g. SOX or c-MYC
- A61K40/4243—Wilms tumor 1 [WT1]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Cell Biology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Biochemistry (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Microbiology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
General Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Virology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Tropical Medicine & Parasitology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)

DK05727848.3T 2004-03-31 2005-03-30 Cancerantigenpeptider der er afledt af WT1 DK1731605T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2004105219		2004-03-31
PCT/JP2005/006113 WO2005095598A1 (ja)	2004-03-31	2005-03-30	Ｗｔ１由来の癌抗原ペプチド

Publications (1)

Publication Number	Publication Date
DK1731605T3 true DK1731605T3 (da)	2010-05-25

Family

ID=35063778

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK10152702.6T DK2186896T3 (da)	2004-03-31	2005-03-30	Cancerantigenpeptider afledt fra WT1
DK05727848.3T DK1731605T3 (da)	2004-03-31	2005-03-30	Cancerantigenpeptider der er afledt af WT1

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK10152702.6T DK2186896T3 (da)	2004-03-31	2005-03-30	Cancerantigenpeptider afledt fra WT1

Country Status (11)

Country	Link
US (3)	US7622119B2 (da)
EP (2)	EP1731605B1 (da)
JP (1)	JP4886507B2 (da)
AT (1)	ATE462003T1 (da)
DE (1)	DE602005020121D1 (da)
DK (2)	DK2186896T3 (da)
ES (2)	ES2556232T3 (da)
PL (1)	PL1731605T3 (da)
PT (1)	PT1731605E (da)
SI (1)	SI1731605T1 (da)
WO (1)	WO2005095598A1 (da)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2337743C (en)	1998-07-31	2015-07-07	Yoshihiro Oka	Tumor antigen based on products of the tumor suppressor gene wt1
JP3728439B2 (ja)	2001-03-22	2005-12-21	治夫杉山	Ｗｔ１改変ペプチド
WO2003028757A1 (en) *	2001-09-28	2003-04-10	Haruo Sugiyama	Novel method of inducing antigen-specific t cells
ES2538486T3 (es) *	2002-09-12	2015-06-22	International Institute Of Cancer Immunology, Inc.	Preparación de péptidos antigénicos contra el cáncer
KR20120054644A (ko)	2003-01-15	2012-05-30	추가이 세이야쿠 가부시키가이샤	이량체화 펩티드
ATE538809T1 (de) *	2003-06-27	2012-01-15	Int Inst Cancer Immunology Inc	Verfahren zur auswahl von geeigneten patienten für den wt1-impfstoff
CA2544214C (en)	2003-11-05	2018-08-28	International Institute Of Cancer Immunology, Inc.	Hla-dr-binding antigen peptide derived from wt1
JP4886507B2 (ja) *	2004-03-31	2012-02-29	株式会社癌免疫研究所	Ｗｔ１由来の癌抗原ペプチド
EP1951281B1 (en)	2005-10-17	2015-04-15	Sloan Kettering Institute For Cancer Research	Wt1 hla class ii-binding peptides and compositions and methods comprising same
CN105315347A (zh)	2005-11-30	2016-02-10	株式会社癌免疫研究所	新型肽化合物
EP2385117B1 (en)	2006-02-22	2016-07-27	International Institute of Cancer Immunology, Inc.	HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
EP3117836A1 (en)	2006-04-10	2017-01-18	Sloan Kettering Institute For Cancer Research	Immunogenic wt-1 peptides and uses thereof
EP2980219B1 (en)	2006-12-28	2018-11-14	International Institute of Cancer Immunology, Inc.	Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same
EP2119778B1 (en) *	2007-02-27	2015-11-04	International Institute of Cancer Immunology, Inc.	Method for activation of helper T cell and composition for use in the method
KR101669279B1 (ko)	2007-03-05	2016-10-26	인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드	암 항원 특이적 ｔ 세포의 수용체 유전자 및 그것에 따라 코드되는 펩티드 및 이들의 사용
JPWO2009066462A1 (ja) *	2007-11-20	2011-04-07	日本電気株式会社	細胞傷害性ｔ細胞の誘導方法、細胞傷害性ｔ細胞の誘導剤、およびそれを用いた医薬組成物およびワクチン
KR20110053836A (ko) *	2009-11-16	2011-05-24	삼성에스디아이 주식회사	리튬 폴리머 이차 전지
EP2626418B8 (en)	2010-10-05	2021-03-24	International Institute of Cancer Immunology, Inc.	Method for activating helper t cell
AU2012276908A1 (en)	2011-06-28	2014-02-20	International Institute Of Cancer Immunology, Inc.	Receptor gene for peptide cancer antigen-specific T cell
US9539299B2 (en) *	2011-10-27	2017-01-10	International Institute Of Cancer Immunology, Inc.	Combination therapy with WT1 peptide vaccine and temozolomide
JP6368243B2 (ja)	2011-11-11	2018-08-08	フレッドハッチンソンキャンサーリサーチセンター	がんのためのサイクリンａ１に標的化されたｔ細胞免疫療法
EP2802347B1 (en)	2012-01-13	2019-01-09	Memorial Sloan Kettering Cancer Center	Immunogenic wt-1 peptides and methods of use thereof
CA2884366A1 (en)	2012-09-12	2014-03-20	International Institute Of Cancer Immunology, Inc.	Antigen-specific helper t-cell receptor genes
ES2805337T3 (es)	2012-12-17	2021-02-11	Otsuka Pharma Co Ltd	Método para activar células T auxiliares
US10815273B2 (en)	2013-01-15	2020-10-27	Memorial Sloan Kettering Cancer Center	Immunogenic WT-1 peptides and methods of use thereof
SI2945647T1 (sl)	2013-01-15	2021-01-29	Memorial Sloan Kettering Cancer Center	Imunogeni peptidi WT-1 in postopki za uporabo le-teh
RU2687144C2 (ru)	2013-02-05	2019-05-07	Нитто Денко Корпорейшн	Композиция противораковой вакцины, содержащей пептид wt1, для трансдермального введения
RU2685933C2 (ru)	2013-02-05	2019-04-23	Нитто Денко Корпорейшн	Композиция противораковой вакцины, содержащая пептид wt1, для трансдермального введения
CA2840937A1 (en)	2013-02-05	2014-08-05	Nitto Denko Corporation	Vaccine composition for transdermal administration
KR20140100422A (ko)	2013-02-05	2014-08-14	닛토덴코 가부시키가이샤	백신 조성물
KR102045029B1 (ko)	2013-02-05	2019-11-14	닛토덴코 가부시키가이샤	점막 투여용 ｗｔ1 펩티드 암 백신 조성물
IN2014CH00393A (da)	2013-02-05	2015-04-03	Nitto Denko Corp
JP2014169275A (ja)	2013-02-05	2014-09-18	Nitto Denko Corp	粘膜投与用ワクチン組成物
CN103961698A (zh)	2013-02-05	2014-08-06	日东电工株式会社	经皮或粘膜给予用疫苗组合物
US10023841B2 (en) *	2014-05-23	2018-07-17	Baylor Research Institute	Methods and compositions for treating breast cancer with dendritic cell vaccines
CN107074970B (zh)	2014-08-04	2021-07-30	弗雷德哈钦森癌症研究中心	特异性针对wt-1的t细胞免疫疗法
CA2974066C (en)	2014-12-25	2025-05-06	International Institute Of Cancer Immunology, Inc.	METHOD FOR MODIFYING A T LYMPHOCYTE POPULATION
GB201504502D0 (en) *	2015-03-17	2015-04-29	Immatics Biotechnologies Gmbh	Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
CN106610423A (zh) *	2015-10-26	2017-05-03	复旦大学	评价疫苗疗效的细胞免疫学检测试剂盒及其储存方法
WO2018088439A1 (ja)	2016-11-09	2018-05-17	国立大学法人大阪大学	Ｔ細胞集団の改変方法
EP3647433B1 (en) *	2017-06-30	2023-04-12	Osaka University	Method for predicting effect of tumor immunotherapy using tumor cytotoxic activity of peripheral blood t cells as index
CA3132845A1 (en)	2019-03-11	2020-09-17	Fred Hutchinson Cancer Research Center	High avidity wt1 t cell receptors and uses thereof
WO2021034976A1 (en)	2019-08-20	2021-02-25	Fred Hutchinson Cancer Research Center	T-cell immunotherapy specific for wt-1
CN111978375B (zh) *	2020-08-28	2022-10-04	深圳市乐土生物医药有限公司	具有细胞毒性t细胞诱导能力的蛋白质或多肽
CN112250752B (zh) *	2020-12-21	2021-03-26	中生康元生物科技(北京)有限公司	肿瘤新抗原表位肽及其应用
CA3201115A1 (en)	2020-12-21	2022-06-30	Shanshan LANG	Protease-activating cd45-gate car
MX2023008809A (es)	2021-01-29	2023-08-04	Allogene Therapeutics Inc	ATENUACIÓN O INACTIVACIÓN DE UNO O MÁS DE TAP2, NLRC5, ß2M, TRAC, RFX5, RFXAP Y RFXANK PARA MITIGAR EL RECONOCIMIENTO DE CÉLULAS T DE PRODUCTOS CELULARES ALOGÉNICOS.
CN119654406A (zh)	2022-07-29	2025-03-18	艾洛基治疗公司	具有降低的基因表达以减轻免疫细胞识别的经工程化的细胞
WO2025096560A1 (en)	2023-10-30	2025-05-08	Allogene Therapeutics, Inc.	Engineered cells

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5840839A (en) *	1996-02-09	1998-11-24	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
CA2337743C (en) *	1998-07-31	2015-07-07	Yoshihiro Oka	Tumor antigen based on products of the tumor suppressor gene wt1
US20030235557A1 (en) *	1998-09-30	2003-12-25	Corixa Corporation	Compositions and methods for WT1 specific immunotherapy
HK1039782B (en) *	1998-09-30	2008-11-14	Corixa Corporation	Compositions and methods for wt1 specific immunotherapy
GB9823897D0 (en)	1998-11-02	1998-12-30	Imp College Innovations Ltd	Immunotherapeutic methods and molecules
WO2001025273A2 (en) *	1999-10-04	2001-04-12	Corixa Corporation	Compositions and methods for wt1 specific immunotherapy
US20030082194A1 (en) *	2000-02-22	2003-05-01	Alexander Gaiger	Compositions and methods for diagnosis and therapy of malignant mesothelioma
JP3728439B2 (ja) *	2001-03-22	2005-12-21	治夫杉山	Ｗｔ１改変ペプチド
WO2003028757A1 (en) *	2001-09-28	2003-04-10	Haruo Sugiyama	Novel method of inducing antigen-specific t cells
JPWO2003028758A1 (ja) *	2001-09-28	2005-01-13	治夫杉山	抗原特異的ｔ細胞の誘導方法
JP4365784B2 (ja) *	2002-06-12	2009-11-18	株式会社癌免疫研究所	Ｈｌａ−ａ２４拘束性癌抗原ペプチド
ES2538486T3 (es) *	2002-09-12	2015-06-22	International Institute Of Cancer Immunology, Inc.	Preparación de péptidos antigénicos contra el cáncer
JP4480580B2 (ja) *	2002-09-20	2010-06-16	株式会社癌免疫研究所	Ｗｔ１置換型ペプチド
KR20120054644A (ko) *	2003-01-15	2012-05-30	추가이 세이야쿠 가부시키가이샤	이량체화 펩티드
ATE538809T1 (de) *	2003-06-27	2012-01-15	Int Inst Cancer Immunology Inc	Verfahren zur auswahl von geeigneten patienten für den wt1-impfstoff
CA2544214C (en) *	2003-11-05	2018-08-28	International Institute Of Cancer Immunology, Inc.	Hla-dr-binding antigen peptide derived from wt1
JP4886507B2 (ja) *	2004-03-31	2012-02-29	株式会社癌免疫研究所	Ｗｔ１由来の癌抗原ペプチド

2005
- 2005-03-30 JP JP2006511744A patent/JP4886507B2/ja not_active Expired - Fee Related
- 2005-03-30 DE DE602005020121T patent/DE602005020121D1/de not_active Expired - Lifetime
- 2005-03-30 DK DK10152702.6T patent/DK2186896T3/da active
- 2005-03-30 US US10/594,507 patent/US7622119B2/en not_active Expired - Fee Related
- 2005-03-30 WO PCT/JP2005/006113 patent/WO2005095598A1/ja not_active Ceased
- 2005-03-30 ES ES10152702.6T patent/ES2556232T3/es not_active Expired - Lifetime
- 2005-03-30 DK DK05727848.3T patent/DK1731605T3/da active
- 2005-03-30 SI SI200530954T patent/SI1731605T1/sl unknown
- 2005-03-30 PL PL05727848T patent/PL1731605T3/pl unknown
- 2005-03-30 EP EP05727848A patent/EP1731605B1/en not_active Expired - Lifetime
- 2005-03-30 EP EP10152702.6A patent/EP2186896B1/en not_active Expired - Lifetime
- 2005-03-30 AT AT05727848T patent/ATE462003T1/de active
- 2005-03-30 PT PT05727848T patent/PT1731605E/pt unknown
- 2005-03-30 ES ES05727848T patent/ES2341785T3/es not_active Expired - Lifetime
2009
- 2009-09-04 US US12/554,151 patent/US8388975B2/en not_active Expired - Fee Related
2013
- 2013-01-24 US US13/748,984 patent/US20130196427A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1731605A1 (en)	2006-12-13
SI1731605T1 (sl)	2010-07-30
JP4886507B2 (ja)	2012-02-29
PT1731605E (pt)	2010-04-14
ATE462003T1 (de)	2010-04-15
DK2186896T3 (da)	2015-12-21
WO2005095598A1 (ja)	2005-10-13
HK1144305A1 (en)	2011-02-11
US20100062013A1 (en)	2010-03-11
EP1731605A4 (en)	2007-11-07
PL1731605T3 (pl)	2010-08-31
ES2341785T3 (es)	2010-06-28
JPWO2005095598A1 (ja)	2008-02-21
ES2556232T3 (es)	2016-01-14
EP1731605B1 (en)	2010-03-24
US7622119B2 (en)	2009-11-24
EP2186896A1 (en)	2010-05-19
US8388975B2 (en)	2013-03-05
US20080152631A1 (en)	2008-06-26
US20130196427A1 (en)	2013-08-01
DE602005020121D1 (de)	2010-05-06
EP2186896B1 (en)	2015-11-04

Publication	Publication Date	Title
DK1731605T3 (da)	2010-05-25	Cancerantigenpeptider der er afledt af WT1
NO20063624L (no)	2006-10-03	FC region varianter
ATE428727T1 (de)	2009-05-15	Neue, an den erythropoietinrezeptor bindende peptide
ATE466084T1 (de)	2010-05-15	Hla-a24-restringiertes krebsantigenpeptid
DE60310731D1 (de)	2007-02-08	Neue, von noraporphin abgeleitete moleküle
EA201100868A1 (ru)	2011-10-31	Противоопухолевые комбинации, содержащие антитела, специфически распознающие cd38, и цитарабин
CY1110980T1 (el)	2015-06-11	Εμβολιο συνδυασμων πεπτιδιων εναντια στην αλλεργια απο γατες
DK1625156T3 (da)	2013-01-07	Peptider, der bindes til erythropoietinreceptoren
EA200701825A1 (ru)	2008-04-28	Вакцины против хламидиоза
EP2006377A4 (en)	2009-12-09	NEW TUMORANT PEPTIDES
NO20052149D0 (no)	2005-05-02	Vaksine.
DK1881845T3 (da)	2010-06-07	Nipah-virusvacciner
DK1628989T3 (da)	2007-10-08	Hidtil ukendte, 14- og 15-leddet ring-forbindelser
ITMI20030107A1 (it)	2004-07-25	Peptidi derivati da rantes.
EA200801180A1 (ru)	2008-08-29	Селективные пептидные агонисты рецептора vpac2
DE602005007364D1 (de)	2008-07-17	Peptidcyclisierung
AP2415A (en)	2012-06-01	Bacteriocin Inducer peptides.
DE602004012207D1 (de)	2008-04-17	Fluoreszent markierte Ghrelin-Peptide
CY1116106T1 (el)	2017-02-08	Μεθοδος προληψης ή θεραπεια μολυνσης m. tuberculosis
DE602005014597D1 (de)	2009-07-09	Peptide zur Unterscheidung von Prionen
ES1055913Y (es)	2004-09-16	Linterna.
CY1110086T1 (el)	2015-01-14	Πεπτιδια καρκινικου αντιγονου προερχομενα απο wt1
ITTO20040492A1 (it)	2004-10-15	Carter antimanipolazione bancomat.
ITMO20030249A1 (it)	2005-03-17	Forno per manufatti ceramici.
ITMI20031686A1 (it)	2005-02-28	Generatiri di turbo codici.